Effectiveness of a Brief Intensive Trauma Treatment for Adolescents With (s)PTSD: a Multi-center RCT

NCT ID: NCT06143982

Last Updated: 2023-11-22

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

RECRUITING

Clinical Phase

NA

Total Enrollment

100 participants

Study Classification

INTERVENTIONAL

Study Start Date

2022-10-05

Study Completion Date

2026-02-01

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The primary objective of this study is to examine the effectiveness of a Brief Intensive Trauma Treatment (BITT) for adolescents with (s)PTSD.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

This study is a multi-center, single-blinded RCT. Adolescents (12-18 years old) with (s)PTSD will be randomly allocated by an independent researcher to the BITT (n=50) versus a waitlist control group (WLCG; n=50), stratified by center. Measurements are done at comparable time intervals for both groups: at pre-treatment (T0), directly after BITT or WLCG (T1) and at 3 (T2), 6 (T3) and 9 (T4) months follow-up. The WLCG receives BITT after the 3 months follow-up.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Post-traumatic Stress Disorder

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

A two-arm, mutli-center, randomized controlled trial (RCT). Adolescents (12-18 years old) with (s)PTSD will be randomly allocated by an independent researcher to the intervention group (n=50) versus a waitlist control group (WLCG; n=50), stratified by center. If allocated to the intervention group, participants follow the Brief Intensive Trauma Treatment (BITT). When allocated to the WLCG, participants receive BITT after a 3 months waiting period. Measurements are done at comparable time intervals for both groups: at pre-treatment (T0), directly after BITT or WLCG (T1) and at 3 (T2), 6 (T3) and 9 (T4) months follow-up.
Primary Study Purpose

TREATMENT

Blinding Strategy

DOUBLE

Investigators Outcome Assessors

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Brief Intensive Trauma Treatment

If allocated to the intervention group, participants follow the Brief Intensive Trauma Treatment (BITT).

Group Type EXPERIMENTAL

Brief Intensive Trauma Treatment

Intervention Type BEHAVIORAL

BITT is an outpatient, intensive, one-week individual trauma therapy program. BITT is based on well-established protocols, consisting of two 90-minutes trauma therapy sessions a day (trauma exposure in the morning and EMDR in the afternoon), two psychomotor therapy sessions a day (1x60 minutes, 1x45 minutes), one 90-minutes psycho-education and social support skill training for parents a day, and a 90-minutes family therapy session at the end of the week (sharing the trauma narrative).

Waitlist control group

When allocated to the WLCG, participants receive BITT after a 3 months waiting period. The WLCG receives no care during the treatment phase (one week) of the intervention group. Besides this week the WLCG can undergo every treatment including EMDR and TF-CBT during the 3 months waiting period.

Group Type NO_INTERVENTION

No interventions assigned to this group

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Brief Intensive Trauma Treatment

BITT is an outpatient, intensive, one-week individual trauma therapy program. BITT is based on well-established protocols, consisting of two 90-minutes trauma therapy sessions a day (trauma exposure in the morning and EMDR in the afternoon), two psychomotor therapy sessions a day (1x60 minutes, 1x45 minutes), one 90-minutes psycho-education and social support skill training for parents a day, and a 90-minutes family therapy session at the end of the week (sharing the trauma narrative).

Intervention Type BEHAVIORAL

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

In order to be eligible to participate in this study, a subject must meet all of the following criteria:

* 12-18 years of age;
* with a history of psychological trauma (conform the Life Events Checklist of the Clinician Administered PTSD Scale for Children and Adolescents DSM-5 (CAPS-CA DSM-5) (Nader, 2004; van Meijel et al., 2019);
* at least subthreshold PTSD criteria, conform the CAPS-CA DSM-5, i.e.;

* fully meeting criterion A, F and G and at least one symptom of criteria B, C, D and E;
* or fully meeting criterion A, F, G and at least the B, C, D or E symptom clusters;
* and written informed consent must be provided by the adolescent and, for adolescents aged 12-15 years, all legal guardians.

Exclusion Criteria

A potential subject who meets any of the following criteria will be excluded from participation in this study in case of:

* inability to speak and write Dutch;
* estimated or determined mental retardation (IQ \<70);
* suffering from ongoing trauma by a parent who is part of the adolescent's current primary-care system.
Minimum Eligible Age

12 Years

Maximum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Prof. dr. R.J.L. (Ramón) Lindauer

Principal Investigator

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Ramón Lindauer, Prof. dr.

Role: PRINCIPAL_INVESTIGATOR

Amsterdam UMC, location AMC/Levvel

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Mental Health Caribbean

Kralendijk, , Bonaire, Saint Eustatius and Saba

Site Status RECRUITING

Amsterdam UMC, location AMC/Levvel

Amsterdam, North Holland, Netherlands

Site Status RECRUITING

Karakter

Almelo, Overijsel, Netherlands

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

Bonaire, Saint Eustatius and Saba Netherlands

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Myrna Westerveld, MSc

Role: CONTACT

+31643300014

Malindi van der Mheen, Dr.

Role: CONTACT

+31205663383

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Marielle Hoekstra, MSc

Role: primary

+599-7170125

Myrna Westerveld, MSc

Role: primary

+31643300014

Rik Knipschild,, MSc

Role: primary

31629607864

References

Explore related publications, articles, or registry entries linked to this study.

Westerveld MM, van der Mheen M, Knipschild R, Maijer K, de Keizer-Altink ME, Albisser N, Hoekstra MJE, Timmermans-Jansen A, Zijp R, Krabbendam AA, van Steensel FJAB, Kan KJ, Huyser C, Staal WG, Utens EMWJ, Lindauer RJL. Short- and Long-Term Effectiveness of Brief Intensive Trauma Treatment for Adolescents With Posttraumatic Stress Disorder and Their Caregivers: Protocol for a Multicenter Randomized Controlled Trial. JMIR Res Protoc. 2025 Apr 30;14:e66115. doi: 10.2196/66115.

Reference Type DERIVED
PMID: 40306642 (View on PubMed)

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

Effectstudie BITT

Identifier Type: -

Identifier Source: org_study_id